홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Phenylacetic Acid → Phorbol

HRID 43335
노트
인쇄 미리보기

반응식

HRID 43335 반응식
[C:1]([O-:4])(=O)[CH3:2].C([O-])(=[O:7])C.C([O-])(=O)C.C([O-])(=O)C.[Pb+4].C1(CC(O)=O)C=CC=CC=1.N1CC=CN1.N=N.[CH3:35][C@H:36]1[C@:42]2([OH:56])[CH:43]3[C@:48]([OH:54])([CH2:49]C(CO)=[CH:51][C@H:41]2[C@H:40]([C:57]([CH3:59])=[CH2:58])[C:38](=[O:39])[CH2:37]1)[C:46](=[O:47])[C:45]([CH3:55])=[CH:44]3>>[CH3:35][C@H:36]1[C@:42]2([OH:56])[C@H:43]3[C@:48]([OH:54])([CH2:49][C:2]([CH2:1][OH:4])=[CH:51][C@H:41]2[C@@H:40]2[C:57]([CH3:58])([CH3:59])[C@:38]2([OH:39])[C@@H:37]1[OH:7])[C:46](=[O:47])[C:45]([CH3:55])=[CH:44]3
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 5

HCID 999Phenylacetic AcidHCID 123195DiimineHCID 41560032,3-dihydro-1H-pyrazoleHCID 102259583CrotophorboloneHCID 178418268HCID 178418268, 화합물2회

생성물 1

HCID 442070Phorbol

실험 절차

Another embodiment is shown in FIG. 8. In this embodiment, the acidic hydrolysis of phorbol produces crotophorbolone, which is then used as the starting material. First, treatment of crotophorbolone with hydrazine in the presence of acetic acid selectively affords the C13 hydrazone (not shown), which without isolation is cyclized to pyrazoline S5a. Oxidation of pyrazalone S5a with lead (IV) tetraacetate gives cyclic diazene S7a, allowing for concomitant direct introduction of a C13 acetate group and a diazene bridge between C13 and C15. Other C13 esters can also be directly introduced with this procedure by using the corresponding lead (IV) carboxylate or related oxidants. Photolysis of cyclic diazene S7a results in the extrusion of nitrogen and reestablishment of the C13-15 cyclopropane bond, providing prostratin in high yield and in a remarkably concise four—step sequence from crotophorbolone, or five steps from phorbol with a 12-16% overall yield, producing over 100 mg of prostratin from a single run. DPP can be made in a similar manner. In this case, the acetate ligands of lead tetraacetate are exchanged by premixing with an excess of phenylacetic acid. The resulting salt induces the oxidative conversion of pyrazoline S5a to diazene S7b. (in 36% yield for three steps from crotophorbolone). Subsequent photolysis affords the natural product and therapeutic lead DPP in 90% yield, or 13% overall yield from phorbol. Details of this embodiment are described below in EXAMPLES 7 and 11.

후처리

  1. customSubsequent photolysis affords the natural product and therapeutic lead DPP in 90% yield, or 13%

출처 및 근거

ORD 기록
ord-d390fe90fb204762a5ad2addb1141dd3
출처 데이터셋
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08536378B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트